Skip To Main Content
Lilly
Menu closed
Lilly
  • Account Login / Register
  • Medical Home
    • Medical Information
  • Medical Education
  • Science
Ask Lilly

We're here to help.

Chat
Chat with us Chat with us
Question Contact Us
Expand contact lilly
Lilly

You are now leaving the LillyMedical.com website

The link you clicked on will take you to a site maintained by a third party, which is solely responsible for its content. Lilly USA, LLC does not control, influence, or endorse this site, and the opinions, claims, or comments expressed on this site should not be attributed to Lilly USA, LLC. Lilly USA, LLC is not responsible for the privacy policy of any third-party websites. We encourage you to read the privacy policy of every website you visit.
Click "Continue" to proceed or "Return" to return to LillyMedical.com.

  1. Medical Information Right
  2. Diabetes Right
  3. Humulin Therapies Right
  4. HUMULIN® (insulin human) and HUMALOG® (insulin lispro): Pharmacodynamic Properties
Search Humulin (type in keywords)
Search Medical Information

If you wish to report an adverse event or product complaint, please call 1-800-LILLYRX (1-800-545-5979)

Loading icon

Humulin® Therapies

Humulin® R (U-100) (regular insulin human injection, USP [rDNA origin])

100 units/mL
Full Prescribing Information

Humulin® R (U-500) (regular U-500 [concentrated] insulin human injection, USP [rDNA origin])

500 units/mL
Full Prescribing Information

Humulin® 70/30 (70% human insulin isophane suspension and 30% human insulin injection [rDNA origin])

100 units/mL
Full Prescribing Information

Humulin® N U-100 (human insulin [rDNA origin] isophane suspension)

100 units/mL
Full Prescribing Information

This information is provided in response to your request. Resources may contain information about doses, uses, formulations and populations different from product labeling. See Prescribing Information above, if applicable.

HUMULIN® (insulin human) and HUMALOG® (insulin lispro): Pharmacodynamic Properties

The pharmacodynamic properties vary among insulin products and among different individuals.

Detailed Information

  • The time course of action of any insulin may vary considerably in different individuals or at different times within the same individual.1,2

  • As with all insulin preparations, the duration of action of the specific insulin product is dependent on site of injection, injection site blood supply, temperature, meal pattern, coadministered medications, physical activity, and renal or hepatic function.1,2

Humalog-Specific Information

  • Products containing Humalog differ from regular human insulin because of their rapid onset of action as well as a shorter duration of activity. When used as a mealtime insulin, the dose of Humalog should be given within 15 minutes before or immediately after the meal.1

  • Doses of the Humalog premixtures (Humalog Mix50/50 or Humalog Mix75/25) should be given within 15 minutes before a meal.3,4

  • One unit of Humalog has the same glucose-lowering effect as 1 unit of regular human insulin, but its effect is more rapid and of shorter duration.1 Additional information may be found in the prescribing information for the specific Humalog product.

Pharmacodynamic Properties of Lilly Insulin Products

 

Table 1. Onset, Peak Insulin Concentration, and Duration of Action for Lilly Insulin Products1-7

Insulin Product

Onset

Dose (units/kg)a

Time to Peak Insulin Concentrationb

Duration

Humalog

More rapid onset than regular human insulin

0.1-0.4

30 to 90 minutes

Shorter than regular human insulin

Humulin R U-100

Approximately 30 minutes (10 to 75 minutes) 

0.05-0.4

36 to 150 minutes

Approximately 8 hours (range, 3 to 14 hours)

Humulin R U-500

Less than 15 minutes

0.4-0.6 and 0.8-1.3

4 hours (0.5 to 8 hours)c and 8 hours (0.5 to 8 hours)d

21 hours (range, 13 to 24 hours)e

Humalog Mix75/25f

More rapid than regular human insulin

0.3

1 hour (30 minutes to 4 hours)

22 hours (range, 13 to 22 hours)

Humulin 70/30g

Approximately 50 minutes (range, 30 to 90 minutes)

0.3

2.2 hours (1 to 5 hours)

Approximately 23 hours (range, 18 to 24 hours)

Humalog Mix50/50f

More rapid than regular human insulin

0.3

1 hour (45 minutes to 13.5 hours)

22 hours (range, 11 to 22 hours)

Humulin N

Slower than regular human insulin

0.4

4 hours (1 to 12 hours)

Longer than regular human insulin, up to 24 hours

a Euglycemic clamp study of healthy subjects.

b Data presented as median (range) if available. 

c 0.4-0.6 units/kg. 

d 0.8-1.3 units/kg.

e Credited to the high concentration of the preparation.

f Humalog Mix products are a mixture of insulin lispro, a rapid-acting insulin, and insulin lispro protamine suspension, an intermediate-acting insulin.

g Humulin 70/30 is a mixture of human insulin isophane suspension, an intermediate-acting insulin, and regular human insulin, a rapid-acting insulin.

Enclosed Prescribing Information

HUMALOG® (insulin lispro injection), for subcutaneous or intravenous use, Lilly

HUMALOG® Mix50/50 (50% insulin lispro protamine suspension and 50% insulin lispro injection [rDNA origin]), Lilly

HUMALOG® Mix75/25™ (insulin lispro protamine and insulin lispro injectable suspension), for subcutaneous use, Lilly

HUMULIN® 70/30 (70% human insulin isophane suspension and 30% human insulin injection [rDNA origin]), injectable suspension, for subcutaneous use, Lilly

HUMULIN® N (human insulin [rDNA origin] isophane suspension), injectable suspension, for subcutaneous use, Lilly

HUMULIN® R U-100 (regular insulin human injection [rDNA origin]), Lilly

HUMULIN® R U-500 (insulin human injection), for subcutaneous use, Lilly

References

1. Humalog [package insert]. Indianapolis, IN: Eli Lilly and Company; 2019.

2. Humulin R U-100 [package insert]. Indianapolis, IN: Eli Lilly and Company; 2019.

3. Humalog Mix50/50 [package insert]. Indianapolis, IN: Eli Lilly and Company; 2019.

4. Humalog Mix75/25 [package insert]. Indianapolis, IN: Eli Lilly and Company; 2019.

5. Humulin R U-500 [package insert]. Indianapolis, IN: Eli Lilly and Company; 2019.

6. Humulin N [package insert]. Indianapolis, IN: Eli Lilly and Company; 2019.

7. Humulin 70/30 [package insert]. Indianapolis, IN: Eli Lilly and Company; 2019.

Date of Last Review: December 02, 2020

Are you satisfied with this content?

Can't find what you're looking for? Contact us for answers to your medical questions.

  • Copyright
  • Terms of Use
  • Privacy Statement
  • Accessibility Statement
  • Sitemap

    This site is intended for US Healthcare Professionals only.

    4.0.17 02/2023 | GLOOTH00001 04/2015 | © Lilly USA, LLC 2023. All rights reserved.

    Product names listed above are trademarks or registered trademarks owned by or licensed to Eli Lilly and Company, its subsidiaries, or affiliates

    facebook twitter linkedin
    visit www.phactmi.org
    Lilly